Type 2 Diabetes Mellitus. non-insulin-dependent-diabetes-mellitus
Conditions
Interventions
Intervention 1: Resveratrol- 240 mg/day with lunch for 8 weeks. Intervention 2: Placebo- 240 mg/day with lunch for 8 weeks.
Treatment - Other
Placebo
Resveratrol- 240 mg/day with lunch for 8 weeks
Placebo- 240 mg/day with lunch for 8 weeks
Sponsors
Vice chancellor for research, Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
45 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: diagnosis of type 2 Diabetes for at least 2 years; willing to participate; BMI more than 25; age between 45 to 70 years old. Exclusion criteria: Significant diseases including cardiovascular, renal and liver diseases, or cancer; pregnancy; lactation; insulin use; weight and BMI change; consumption of nutritional supplements within the past 8 weeks.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Irisin. Timepoint: At baseline and after 8 weeks. Method of measurement: ELISA.;Adiponectin. Timepoint: At beaseline and after 8 weeks. Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar (FBS). Timepoint: At baseline and after 8 weeks. Method of measurement: Biochemical assessment.;HbA1C. Timepoint: At baseline and after 8 weeks. Method of measurement: Biochemical assessment.;Insulin. Timepoint: At baseline and after 8 weeks. Method of measurement: ELISA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Khajehpour
Department of Nutrition, School of Public Health, Iran University of Medical Sciences.
Outcome results
None listed